1-241504161-G-A

Variant summary

Our verdict is Likely pathogenic.
+6 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 6 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO5_SupportingO6_SupportingO7_SupportingO8_Supporting

The NM_000143.4(FH):c.989C>T (p.Thr330Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The gene FH is a tumor suppressor gene (CancerMine: 5 TSG, 1 oncogene, 2 driver citations). The gene FH is a known oncogene (CancerMine: 5 TSG, 1 oncogene, 2 driver citations). The gene FH is a cancer driver gene (CancerMine: 5 TSG, 1 oncogene, 2 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.35). Variant has been reported in ClinVar as Uncertain Significance (★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.T330P: Pathogenic/Likely_pathogenic (ClinVar VariationId 575043, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.T330A: Uncertain_significance (ClinVar VariationId 847461, 2 stars); p.T330S: Uncertain_significance (ClinVar VariationId 460384, 1 star); p.T330= (synonymous): Likely_benign (ClinVar VariationId 1561277, 2 stars); p.T330= (synonymous): Benign/Likely_benign (ClinVar VariationId 3230468, 2 stars) The variant has been observed in cBioPortal in 3 samples across 3 studies and 2 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.).

Frequency

Genomes: not found (cov: 32)

Consequence

FH
NM_000143.4 missense

Scores

16
2
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 9.35

Publications

0 publications found
Variant links:
Genes affected
FH (HGNC:3700): (fumarate hydratase) The protein encoded by this gene is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. It is similar to some thermostable class II fumarases and functions as a homotetramer. Mutations in this gene can cause fumarase deficiency and lead to progressive encephalopathy. [provided by RefSeq, Jul 2008]
FH Gene-Disease associations (from GenCC):
  • hereditary leiomyomatosis and renal cell cancer
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Natera, G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • fumaric aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Natera
  • pheochromocytoma-paraganglioma
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • leiomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000143.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 6 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
O5Same location/impact as known oncogenic
Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 12 pathogenic, 1 benign (OR vs. background: 41.7); Variant does not impact splicing — splice-hotspot path not applicable
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 2.07 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000143.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

FH NM_000143.4
MANE Select
HGVSc / HGVSpc.989C>Tp.Thr330Ile
Exon rankExon 7 of 10
missense
Prot: NP_000134.2

Ensembl Transcripts

FH ENST00000366560.4
TSL:1MANE Select
HGVSc / HGVSpc.989C>Tp.Thr330Ile
Exon rankExon 7 of 10
missense
Prot: ENSP00000355518.4UniProt: P07954-1
FH ENST00000958409.1
HGVSc / HGVSpc.986C>Tp.Thr329Ile
Exon rankExon 7 of 10
missense
Prot: ENSP00000628468.1UniProt: A0ACI8UZJ7
FH ENST00000932939.1
HGVSc / HGVSpc.941C>Tp.Thr314Ile
Exon rankExon 7 of 10
missense
Prot: ENSP00000602998.1UniProt: A0ACI8TNT4

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:32
GnomAD4 genome
Cov:32
Showing 3 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.00 012948 0.0000431 123218
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)

Computational Scores

AlphaGenome AVI
Pathogenic24
AlphaMissense
Benign0.29
BayesDel_addAF
Pathogenic0.56D
BayesDel_noAF
Pathogenic0.57
CADD
Pathogenic28
DANN
Pathogenic1.0
DEOGEN2
Pathogenic0.91D
Eigen
Pathogenic0.99
Eigen_PC
Pathogenic0.95
FATHMM_MKL
Pathogenic0.99D
FuncVEP CTI
Benign0.22
GPN-Star LLR
N/A-7.4
GPN-Star score
N/A7.4
LIST_S2
Pathogenic0.99D
M_CAP
Pathogenic0.82D
MetaRNN
Pathogenic0.93D
MetaSVM
Pathogenic1.0D
Mutation Taster
N/A7/93disease causing
MutationAssessor
Pathogenic3.0M
PhyloP100
Pathogenic9.3
popEVE
Benign-3.4
PrimateAI
Pathogenic0.81D
PROVEAN
Uncertain-3.4D
REVEL
Pathogenic0.92
Sift
Pathogenic0.0D
Sift4G
Uncertain0.0020D
Varity_R
N/A0.84
VESM-3B
Benign-7.5
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.